Two Sigma Investments
AQST icon

Two Sigma Investments’s Aquestive Therapeutics AQST Stock Holding History

Two Sigma Investments’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73M Buy
1,139,404
+758,284
+199% +$3.08M ﹤0.01% 2028
2025
Q4 		$2.46M Buy
+381,120
New +$2.37M ﹤0.01% 2294
2025
Q3 		– Sell
-239,914
Closed -$794K – 3646
2025
Q2 		$794K Sell
239,914
-132,149
-36% -$379K ﹤0.01% 2370
2025
Q1 		$1.08M Buy
372,063
+196,111
+111% +$594K ﹤0.01% 2128
2024
Q4 		$626K Buy
175,952
+42,160
+32% +$194K ﹤0.01% 2429
2024
Q3 		$666K Sell
133,792
-2,836
-2% -$11K ﹤0.01% 2334
2024
Q2 		$355K Buy
136,628
+81,882
+150% +$274K ﹤0.01% 2520
2024
Q1 		$233K Sell
54,746
-112,413
-67% -$374K ﹤0.01% 2655
2023
Q4 		$338K Buy
167,159
+96,078
+135% +$170K ﹤0.01% 2646
2023
Q3 		$109K Sell
71,081
-91,712
-56% -$158K ﹤0.01% 2733
2023
Q2 		$269K Buy
+162,793
New +$294K ﹤0.01% 2547
2020
Q1 		– Sell
-143,521
Closed -$835K – 3061
2019
Q4 		$835K Buy
143,521
+101,755
+244% +$529K ﹤0.01% 2343
2019
Q3 		$133K Buy
+41,766
New +$156K ﹤0.01% 3269
2018
Q4 		– Sell
-44,156
Closed -$773K – 2965
2018
Q3 		$773K Buy
+44,156
New +$728K ﹤0.01% 2164

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's AQST Position: Q1 2026 in Review

Two Sigma Investments increased its Aquestive Therapeutics (AQST) stake by 199% in Q1 2026, buying an estimated $3.08M and bringing the position to 1,139,404 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Two Sigma Investments first reported a position in AQST in Q3 2018 and has held it in 14 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Two Sigma Investments held 1,139,404 shares of Aquestive Therapeutics worth $4.73M as of Q1 2026.
  • Two Sigma Investments bought 758,284 Aquestive Therapeutics shares in Q1 2026, an estimated $3.08M.
  • Aquestive Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2028 holding.
  • Two Sigma Investments first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 14 quarters since.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.